In Canada/nursing study
Nursing Medication Card -HYDROmorphone (Dilaudid)(Kor/Eng)
Shannon.p
2025. 5. 18. 11:00
반응형
Hydromorphone (하이드로몰폰)
- 적응증: 중등도~중증 통증
- 작용: 오피오이드 수용체 작용
- 흡수: 빠른 흡수
- 분포: BBB 통과, 전신
- 대사/배설: 간 대사, 신장 배설
- 부작용: 호흡 억제, 변비, 오심
- 용량: 2~
4mg/4~6시간마다 - 간호 포인트: 호흡수 확인 필수, 중독 가능성 주의
HYDROmorphone (Dilaudid): Allergy, cold, cough remedies(antitussives), opioid
Class | Opioid analgesic 진통제 / antitussive 기침을 억제하는 ; opioid agonist |
Indications | - Moderate to severe pain - Antitussive (in lower doses) |
Therapeutic Effects | - Relief of moderate to severe pain - Suppression of cough |
Absorption | Well absorbed via PO, rectal, subcutaneous (Subcut), and intramuscular (IM) routes |
Distribution | Widely distributed; crosses placenta and enters breast milk |
Protein Binding | ~20% |
Metabolism & Excretion | Metabolized primarily by the liver; excreted via urine |
Adverse Drug Effects (ADE) | CNS: Confusion, sedation CV: Hypotension GI: Constipation |
Dose | - PO ≥50 kg: 4–8 mg every 3–4 hrs as needed - PO <50 kg: 0.05 mg/kg every 3–4 hrs - IV/IM/Subcut ≥50 kg: 0.06 mg/kg q3–4h - <50 kg: 0.015 mg/kg q3–4h |
Considerations | Monitor for respiratory depression, sedation, and constipation; assess pain before and after administration; use with caution in opioid-naive patients |
반응형